Piper Sandler: The rating of Collegium Pharmaceutical (COLL.US) was lowered from an increase in holdings to a neutral rating, and the target price was adjusted from $39.00 to $39.00.
Piper Sandler：下调Collegium Pharmaceutical(COLL.US)评级，由增持调整至中性评级, 目标价由39.00美元调整至39.00美元。
Piper Sandler: The rating of Collegium Pharmaceutical (COLL.US) was lowered from an increase in holdings to a neutral rating, and the target price was adjusted from $39.00 to $39.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.